annual D&A:
$1.25M-$409.00K(-24.71%)Summary
- As of today (June 3, 2025), BCRX annual depreciation & amortization is $1.25 million, with the most recent change of -$409.00 thousand (-24.71%) on December 31, 2024.
- During the last 3 years, BCRX annual D&A has risen by +$469.00 thousand (+60.36%).
- BCRX annual D&A is now -45.04% below its all-time high of $2.27 million, reached on December 31, 2010.
Performance
BCRX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$331.00K+$22.00K(+7.12%)Summary
- As of today (June 3, 2025), BCRX quarterly depreciation & amortization is $331.00 thousand, with the most recent change of +$22.00 thousand (+7.12%) on March 31, 2025.
- Over the past year, BCRX quarterly D&A has increased by +$25.00 thousand (+8.17%).
- BCRX quarterly D&A is now -71.71% below its all-time high of $1.17 million, reached on December 31, 2010.
Performance
BCRX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$1.27M+$25.00K(+2.01%)Summary
- As of today (June 3, 2025), BCRX TTM depreciation & amortization is $1.27 million, with the most recent change of +$25.00 thousand (+2.01%) on March 31, 2025.
- Over the past year, BCRX TTM D&A has dropped by -$285.00 thousand (-18.32%).
- BCRX TTM D&A is now -43.93% below its all-time high of $2.27 million, reached on December 31, 2010.
Performance
BCRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BCRX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.7% | +8.2% | -18.3% |
| 3 y3 years | +60.4% | +4.4% | +38.8% |
| 5 y5 years | +72.1% | +51.8% | +65.9% |
BCRX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.7% | +60.4% | -21.8% | +8.2% | -23.2% | +38.8% |
| 5 y | 5-year | -24.7% | +72.1% | -21.8% | +98.2% | -23.2% | +79.5% |
| alltime | all time | -45.0% | +604.0% | -71.7% | +727.5% | -43.9% | +652.1% |
BCRX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $331.00K(+7.1%) | $1.27M(+2.0%) |
| Dec 2024 | $1.25M(-24.7%) | $309.00K(-0.6%) | $1.25M(-8.4%) |
| Sep 2024 | - | $311.00K(-2.8%) | $1.36M(-7.4%) |
| Jun 2024 | - | $320.00K(+4.6%) | $1.47M(-5.6%) |
| Mar 2024 | - | $306.00K(-27.7%) | $1.56M(-6.0%) |
| Dec 2023 | $1.66M(+15.2%) | $423.00K(+0.7%) | $1.66M(+1.7%) |
| Sep 2023 | - | $420.00K(+3.2%) | $1.63M(+1.9%) |
| Jun 2023 | - | $407.00K(+0.5%) | $1.60M(+4.7%) |
| Mar 2023 | - | $405.00K(+2.3%) | $1.52M(+6.1%) |
| Dec 2022 | $1.44M(+84.9%) | $396.00K(+1.8%) | $1.44M(+18.6%) |
| Sep 2022 | - | $389.00K(+16.1%) | $1.21M(+15.2%) |
| Jun 2022 | - | $335.00K(+5.7%) | $1.05M(+14.8%) |
| Mar 2022 | - | $317.00K(+85.4%) | $916.00K(+17.9%) |
| Dec 2021 | $777.00K(+3.9%) | $171.00K(-25.3%) | $777.00K(-1.1%) |
| Sep 2021 | - | $229.00K(+15.1%) | $786.00K(+8.6%) |
| Jun 2021 | - | $199.00K(+11.8%) | $724.00K(+2.3%) |
| Mar 2021 | - | $178.00K(-1.1%) | $708.00K(-5.3%) |
| Dec 2020 | $748.00K(+3.3%) | $180.00K(+7.8%) | $748.00K(-0.7%) |
| Sep 2020 | - | $167.00K(-8.7%) | $753.00K(-2.0%) |
| Jun 2020 | - | $183.00K(-16.1%) | $768.00K(+0.3%) |
| Mar 2020 | - | $218.00K(+17.8%) | $766.00K(+5.8%) |
| Dec 2019 | $724.00K(-6.0%) | $185.00K(+1.6%) | $724.00K(-1.8%) |
| Sep 2019 | - | $182.00K(+0.6%) | $737.00K(-1.7%) |
| Jun 2019 | - | $181.00K(+2.8%) | $750.00K(-1.3%) |
| Mar 2019 | - | $176.00K(-11.1%) | $760.00K(-1.3%) |
| Dec 2018 | $770.00K(+9.4%) | $198.00K(+1.5%) | $770.00K(+2.1%) |
| Sep 2018 | - | $195.00K(+2.1%) | $754.00K(+2.3%) |
| Jun 2018 | - | $191.00K(+2.7%) | $737.00K(+2.6%) |
| Mar 2018 | - | $186.00K(+2.2%) | $718.00K(+2.0%) |
| Dec 2017 | $704.00K(+45.8%) | $182.00K(+2.2%) | $704.00K(+1.4%) |
| Sep 2017 | - | $178.00K(+3.5%) | $694.00K(+0.4%) |
| Jun 2017 | - | $172.00K(0.0%) | $691.00K(+13.7%) |
| Mar 2017 | - | $172.00K(0.0%) | $608.00K(+25.9%) |
| Dec 2016 | $483.00K(+168.3%) | $172.00K(-1.7%) | $483.00K(+36.4%) |
| Sep 2016 | - | $175.00K(+96.6%) | $354.00K(+59.5%) |
| Jun 2016 | - | $89.00K(+89.4%) | $222.00K(+22.0%) |
| Mar 2016 | - | $47.00K(+9.3%) | $182.00K(+1.1%) |
| Dec 2015 | $180.00K(+1.7%) | $43.00K(0.0%) | $180.00K(+1.7%) |
| Sep 2015 | - | $43.00K(-12.2%) | $177.00K(+1.7%) |
| Jun 2015 | - | $49.00K(+8.9%) | $174.00K(+3.0%) |
| Mar 2015 | - | $45.00K(+12.5%) | $169.00K(-4.5%) |
| Dec 2014 | $177.00K(-41.8%) | $40.00K(0.0%) | $177.00K(-8.8%) |
| Sep 2014 | - | $40.00K(-9.1%) | $194.00K(-11.0%) |
| Jun 2014 | - | $44.00K(-17.0%) | $218.00K(-16.2%) |
| Mar 2014 | - | $53.00K(-7.0%) | $260.00K(-14.5%) |
| Dec 2013 | $304.00K(-51.6%) | $57.00K(-10.9%) | $304.00K(-26.6%) |
| Sep 2013 | - | $64.00K(-25.6%) | $414.00K(-14.8%) |
| Jun 2013 | - | $86.00K(-11.3%) | $486.00K(-12.7%) |
| Mar 2013 | - | $97.00K(-41.9%) | $557.00K(-11.3%) |
| Dec 2012 | $628.00K(-29.1%) | $167.00K(+22.8%) | $628.00K(-12.4%) |
| Sep 2012 | - | $136.00K(-13.4%) | $717.00K(-6.4%) |
| Jun 2012 | - | $157.00K(-6.5%) | $766.00K(-7.6%) |
| Mar 2012 | - | $168.00K(-34.4%) | $829.00K(-6.4%) |
| Dec 2011 | $886.00K(-60.9%) | $256.00K(+38.4%) | $886.00K(-50.8%) |
| Sep 2011 | - | $185.00K(-15.9%) | $1.80M(-6.4%) |
| Jun 2011 | - | $220.00K(-2.2%) | $1.92M(-8.5%) |
| Mar 2011 | - | $225.00K(-80.8%) | $2.10M(-7.3%) |
| Dec 2010 | $2.27M(+40.6%) | $1.17M(+279.9%) | $2.27M(+51.9%) |
| Sep 2010 | - | $308.00K(-22.6%) | $1.49M(-5.4%) |
| Jun 2010 | - | $398.00K(+1.8%) | $1.58M(-21.2%) |
| Mar 2010 | - | $391.00K(-1.1%) | $2.00M(+24.2%) |
| Dec 2009 | $1.61M | $395.50K(+0.4%) | $1.61M(-4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | $394.00K(-52.1%) | $1.68M(-0.8%) |
| Jun 2009 | - | $823.00K(+77.8%) | $1.69M(+4.1%) |
| Dec 2008 | $1.63M(+18.7%) | $462.90K(+13.7%) | $1.63M(-8.7%) |
| Sep 2008 | - | $407.00K(+6.0%) | $1.78M(+7.9%) |
| Jun 2008 | - | $384.00K(+3.2%) | $1.65M(+9.3%) |
| Mar 2008 | - | $372.00K(-39.8%) | $1.51M(+10.3%) |
| Dec 2007 | $1.37M(+69.0%) | $617.70K(+123.0%) | $1.37M(+41.3%) |
| Sep 2007 | - | $277.00K(+13.5%) | $969.30K(+12.5%) |
| Jun 2007 | - | $244.00K(+5.6%) | $861.30K(+3.0%) |
| Mar 2007 | - | $231.00K(+6.3%) | $836.30K(+3.2%) |
| Dec 2006 | $810.30K(-6.3%) | $217.30K(+28.6%) | $810.30K(+1.2%) |
| Sep 2006 | - | $169.00K(-22.8%) | $800.60K(-5.5%) |
| Jun 2006 | - | $219.00K(+6.8%) | $847.60K(+0.2%) |
| Mar 2006 | - | $205.00K(-1.3%) | $845.60K(-2.2%) |
| Dec 2005 | $864.60K(-9.8%) | $207.60K(-3.9%) | $864.60K(-2.8%) |
| Sep 2005 | - | $216.00K(-0.5%) | $889.50K(-2.5%) |
| Jun 2005 | - | $217.00K(-3.1%) | $912.50K(-2.8%) |
| Mar 2005 | - | $224.00K(-3.7%) | $938.50K(-2.1%) |
| Dec 2004 | $958.50K(-13.0%) | $232.50K(-2.7%) | $958.50K(-1.6%) |
| Sep 2004 | - | $239.00K(-1.6%) | $974.50K(-1.6%) |
| Jun 2004 | - | $243.00K(-0.4%) | $990.50K(-4.9%) |
| Mar 2004 | - | $244.00K(-1.8%) | $1.04M(-5.4%) |
| Dec 2003 | $1.10M(-11.6%) | $248.50K(-2.5%) | $1.10M(-5.0%) |
| Sep 2003 | - | $255.00K(-13.3%) | $1.16M(-4.5%) |
| Jun 2003 | - | $294.00K(-3.3%) | $1.21M(-3.9%) |
| Mar 2003 | - | $304.00K(-0.8%) | $1.26M(+1.4%) |
| Dec 2002 | $1.25M(+18.8%) | $306.60K(-1.1%) | $1.25M(+0.6%) |
| Sep 2002 | - | $310.00K(-9.6%) | $1.24M(+3.8%) |
| Jun 2002 | - | $343.00K(+19.5%) | $1.19M(+8.4%) |
| Mar 2002 | - | $287.00K(-4.1%) | $1.10M(+5.0%) |
| Dec 2001 | $1.05M(+56.8%) | $299.40K(+13.0%) | $1.05M(+15.2%) |
| Sep 2001 | - | $265.00K(+6.0%) | $911.20K(+9.8%) |
| Jun 2001 | - | $250.00K(+6.4%) | $830.20K(+10.8%) |
| Mar 2001 | - | $235.00K(+45.8%) | $749.20K(+12.0%) |
| Dec 2000 | $669.20K(+33.8%) | $161.20K(-12.4%) | $669.20K(+10.1%) |
| Sep 2000 | - | $184.00K(+8.9%) | $608.00K(+16.0%) |
| Jun 2000 | - | $169.00K(+9.0%) | $524.00K(-5.6%) |
| Mar 2000 | - | $155.00K(+55.0%) | $555.00K(+11.0%) |
| Dec 1999 | $500.00K(0.0%) | $100.00K(0.0%) | $500.00K(0.0%) |
| Sep 1999 | - | $100.00K(-50.0%) | $500.00K(0.0%) |
| Jun 1999 | - | $200.00K(+100.0%) | $500.00K(0.0%) |
| Mar 1999 | - | $100.00K(0.0%) | $500.00K(0.0%) |
| Dec 1998 | $500.00K(-16.7%) | $100.00K(0.0%) | $500.00K(0.0%) |
| Sep 1998 | - | $100.00K(-50.0%) | $500.00K(-16.7%) |
| Jun 1998 | - | $200.00K(+100.0%) | $600.00K(0.0%) |
| Mar 1998 | - | $100.00K(0.0%) | $600.00K(0.0%) |
| Dec 1997 | $600.00K(+20.0%) | $100.00K(-50.0%) | $600.00K(0.0%) |
| Sep 1997 | - | $200.00K(0.0%) | $600.00K(+20.0%) |
| Jun 1997 | - | $200.00K(+100.0%) | $500.00K(0.0%) |
| Mar 1997 | - | $100.00K(0.0%) | $500.00K(0.0%) |
| Dec 1996 | $500.00K(-16.7%) | $100.00K(0.0%) | $500.00K(-16.7%) |
| Sep 1996 | - | $100.00K(-50.0%) | $600.00K(0.0%) |
| Jun 1996 | - | $200.00K(+100.0%) | $600.00K(+20.0%) |
| Mar 1996 | - | $100.00K(-50.0%) | $500.00K(-16.7%) |
| Dec 1995 | $600.00K(0.0%) | $200.00K(+100.0%) | $600.00K(+20.0%) |
| Sep 1995 | - | $100.00K(0.0%) | $500.00K(-16.7%) |
| Jun 1995 | - | $100.00K(-50.0%) | $600.00K(0.0%) |
| Mar 1995 | - | $200.00K(+100.0%) | $600.00K(0.0%) |
| Dec 1994 | $600.00K | $100.00K(-50.0%) | $600.00K(+20.0%) |
| Sep 1994 | - | $200.00K(+100.0%) | $500.00K(+66.7%) |
| Jun 1994 | - | $100.00K(-50.0%) | $300.00K(+50.0%) |
| Mar 1994 | - | $200.00K | $200.00K |
FAQ
- What is BioCryst Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual D&A year-on-year change?
- What is BioCryst Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly D&A year-on-year change?
- What is BioCryst Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM D&A year-on-year change?
What is BioCryst Pharmaceuticals annual depreciation & amortization?
The current annual D&A of BCRX is $1.25M
What is the all time high annual D&A for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual depreciation & amortization is $2.27M
What is BioCryst Pharmaceuticals annual D&A year-on-year change?
Over the past year, BCRX annual depreciation & amortization has changed by -$409.00K (-24.71%)
What is BioCryst Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of BCRX is $331.00K
What is the all time high quarterly D&A for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly depreciation & amortization is $1.17M
What is BioCryst Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, BCRX quarterly depreciation & amortization has changed by +$25.00K (+8.17%)
What is BioCryst Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of BCRX is $1.27M
What is the all time high TTM D&A for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM depreciation & amortization is $2.27M
What is BioCryst Pharmaceuticals TTM D&A year-on-year change?
Over the past year, BCRX TTM depreciation & amortization has changed by -$285.00K (-18.32%)